Alaunos Therapeutics (TCRT) Competitors $1.68 +0.07 (+4.35%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.68 0.00 (-0.30%) As of 02/21/2025 05:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsInsider TradesOwnershipSEC FilingsShort InterestTrends TCRT vs. AEON, RLMD, TSBX, EDSA, PBM, BFRI, AYTU, CYCN, CELZ, and AIMShould you be buying Alaunos Therapeutics stock or one of its competitors? The main competitors of Alaunos Therapeutics include AEON Biopharma (AEON), Relmada Therapeutics (RLMD), Turnstone Biologics (TSBX), Edesa Biotech (EDSA), Psyence Biomedical (PBM), Biofrontera (BFRI), Aytu BioPharma (AYTU), Cyclerion Therapeutics (CYCN), Creative Medical Technology (CELZ), and AIM ImmunoTech (AIM). These companies are all part of the "pharmaceutical products" industry. Alaunos Therapeutics vs. AEON Biopharma Relmada Therapeutics Turnstone Biologics Edesa Biotech Psyence Biomedical Biofrontera Aytu BioPharma Cyclerion Therapeutics Creative Medical Technology AIM ImmunoTech Alaunos Therapeutics (NASDAQ:TCRT) and AEON Biopharma (NASDAQ:AEON) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, community ranking, valuation, profitability, risk, dividends, earnings and analyst recommendations. Do analysts prefer TCRT or AEON? AEON Biopharma has a consensus price target of $5.00, suggesting a potential upside of 4,056.28%. Given AEON Biopharma's stronger consensus rating and higher possible upside, analysts plainly believe AEON Biopharma is more favorable than Alaunos Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alaunos Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00AEON Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders hold more shares of TCRT or AEON? 27.7% of Alaunos Therapeutics shares are owned by institutional investors. Comparatively, 22.8% of AEON Biopharma shares are owned by institutional investors. 5.1% of Alaunos Therapeutics shares are owned by insiders. Comparatively, 7.0% of AEON Biopharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is TCRT or AEON more profitable? AEON Biopharma's return on equity of 0.00% beat Alaunos Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Alaunos TherapeuticsN/A -267.77% -209.18% AEON Biopharma N/A N/A -994.63% Does the media favor TCRT or AEON? In the previous week, Alaunos Therapeutics' average media sentiment score of 0.00 equaled AEON Biopharma'saverage media sentiment score. Company Overall Sentiment Alaunos Therapeutics Neutral AEON Biopharma Neutral Which has stronger valuation and earnings, TCRT or AEON? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlaunos TherapeuticsN/AN/A-$35.14MN/AN/AAEON BiopharmaN/AN/A-$36.63M$0.180.67 Does the MarketBeat Community believe in TCRT or AEON? AEON Biopharma received 1 more outperform votes than Alaunos Therapeutics when rated by MarketBeat users. Likewise, 100.00% of users gave AEON Biopharma an outperform vote while only 58.33% of users gave Alaunos Therapeutics an outperform vote. CompanyUnderperformOutperformAlaunos TherapeuticsOutperform Votes758.33% Underperform Votes541.67% AEON BiopharmaOutperform Votes8100.00% Underperform VotesNo Votes Which has more volatility & risk, TCRT or AEON? Alaunos Therapeutics has a beta of -0.4, meaning that its stock price is 140% less volatile than the S&P 500. Comparatively, AEON Biopharma has a beta of 0.05, meaning that its stock price is 95% less volatile than the S&P 500. SummaryAEON Biopharma beats Alaunos Therapeutics on 8 of the 11 factors compared between the two stocks. Get Alaunos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TCRT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TCRT vs. The Competition Export to ExcelMetricAlaunos TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.69M$7.04B$5.78B$8.98BDividend YieldN/A2.87%4.78%3.85%P/E RatioN/A6.1326.4618.82Price / SalesN/A313.78457.6880.73Price / CashN/A67.8344.0437.47Price / Book0.436.747.634.64Net Income-$35.14M$138.11M$3.18B$245.69M7 Day Performance3.70%-2.02%-1.82%-2.63%1 Month Performance-4.82%-1.54%0.22%-2.37%1 Year Performance-88.00%-3.14%17.49%13.65% Alaunos Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TCRTAlaunos TherapeuticsN/A$1.68+4.3%N/A-88.0%$2.58M$7,000.000.0040AEONAEON Biopharma2.1962 of 5 stars$0.13-0.8%$5.00+3,776.0%-98.9%$10.32MN/A0.725Gap DownRLMDRelmada Therapeutics4.3158 of 5 stars$0.33+1.3%$4.25+1,176.7%-94.8%$10.04MN/A-0.1210Gap DownTSBXTurnstone Biologics1.5347 of 5 stars$0.41+6.0%$0.45+8.8%-84.1%$9.56M$19.31M-0.1382EDSAEdesa Biotech2.6731 of 5 stars$2.69-17.2%$21.00+680.7%-53.9%$9.33MN/A-1.3920Earnings ReportGap UpHigh Trading VolumePBMPsyence BiomedicalN/A$1.40+9.0%N/A-97.0%$9.21MN/A0.00N/ABFRIBiofrontera2.6492 of 5 stars$1.18+0.9%$7.00+493.2%+13.6%$9.14M$35.36M-0.5270News CoveragePositive NewsAYTUAytu BioPharma1.0333 of 5 stars$1.39+0.4%N/A-55.0%$8.52M$81M-1.13160High Trading VolumeCYCNCyclerion Therapeutics0.7875 of 5 stars$3.12+3.0%N/A-1.1%$8.46M$1.62M0.0030Negative NewsGap DownCELZCreative Medical Technology0.902 of 5 stars$4.74+3.3%N/A+28.0%$8.30M$10,000.00-1.255Gap UpHigh Trading VolumeAIMAIM ImmunoTech1.9945 of 5 stars$0.13-6.9%$2.75+2,031.8%-67.1%$8.23M$200,000.00-0.2720High Trading Volume Related Companies and Tools Related Companies AEON Biopharma Alternatives Relmada Therapeutics Alternatives Turnstone Biologics Alternatives Edesa Biotech Alternatives Psyence Biomedical Alternatives Biofrontera Alternatives Aytu BioPharma Alternatives Cyclerion Therapeutics Alternatives Creative Medical Technology Alternatives AIM ImmunoTech Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TCRT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alaunos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alaunos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
